Press release
United States Orphan Drugs Market Size (Sales Volume) Market Share 2018-2025
Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Orphan Drugs in these regions, from 2013 to 2025 (forecast)
Get the sample copy of this report @ https://www.marketresearchreports.biz/sample/sample/1721664
United States Orphan Drugs market competition by top manufacturers/players, with Orphan Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Novartis AG
Bristol-Myers Squibb Company
Celgene Corporation
F. Hoffmann-La Roche Ltd.
Pfizer, Inc.
Sanofi S.A.
Alexion Pharmaceuticals, Inc.
Eli Lilly and Company
Novo Nordisk A/S
AstraZeneca
Eisai Co., Ltd.
Daiichi Sankyo Company Limited
Bayer AG
GlaxoSmithKline
Merck & Co., Inc.
Johnson & Johnson
Biogen, Inc.
Shire
Amgen, Inc.
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Oncology
Gastrointestinal
Pulmonary
Neurology
Hematology
Cardio-vascular
Metabolic disorders
Endocrinology
Infectious diseases
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Hospital Pharmacies
Speciality Pharmacies
Retail pharmacies
Others
Request for complete TOC of this report @ https://www.marketresearchreports.biz/reports/1721664/united-states-orphan-drugs-report-market-research-reports/toc
Table of Contents
United States Orphan Drugs Market Report 2018
1 Orphan Drugs Overview
1.1 Product Overview and Scope of Orphan Drugs
1.2 Classification of Orphan Drugs by Product Category
1.2.1 United States Orphan Drugs Market Size (Sales Volume) Comparison by Type (2013-2025)
1.2.2 United States Orphan Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
1.2.3 Oncology
1.2.4 Gastrointestinal
1.2.5 Pulmonary
1.2.6 Neurology
1.2.7 Hematology
1.2.8 Cardio-vascular
1.2.9 Metabolic disorders
1.2.10 Endocrinology
1.2.11 Infectious diseases
1.2.12 Others
1.3 United States Orphan Drugs Market by Application/End Users
1.3.1 United States Orphan Drugs Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
1.3.2 Hospital Pharmacies
1.3.3 Speciality Pharmacies
1.3.4 Retail pharmacies
1.3.5 Others
1.4 United States Orphan Drugs Market by Region
1.4.1 United States Orphan Drugs Market Size (Value) Comparison by Region (2013-2025)
1.4.2 The West Orphan Drugs Status and Prospect (2013-2025)
1.4.3 Southwest Orphan Drugs Status and Prospect (2013-2025)
1.4.4 The Middle Atlantic Orphan Drugs Status and Prospect (2013-2025)
1.4.5 New England Orphan Drugs Status and Prospect (2013-2025)
1.4.6 The South Orphan Drugs Status and Prospect (2013-2025)
1.4.7 The Midwest Orphan Drugs Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Orphan Drugs (2013-2025)
1.5.1 United States Orphan Drugs Sales and Growth Rate (2013-2025)
1.5.2 United States Orphan Drugs Revenue and Growth Rate (2013-2025)
2 United States Orphan Drugs Market Competition by Players/Suppliers
2.1 United States Orphan Drugs Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Orphan Drugs Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Orphan Drugs Average Price by Players/Suppliers (2013-2018)
2.4 United States Orphan Drugs Market Competitive Situation and Trends
2.4.1 United States Orphan Drugs Market Concentration Rate
2.4.2 United States Orphan Drugs Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Orphan Drugs Manufacturing Base Distribution, Sales Area, Product Type
3 United States Orphan Drugs Sales (Volume) and Revenue (Value) by Region (2013-2018)
3.1 United States Orphan Drugs Sales and Market Share by Region (2013-2018)
3.2 United States Orphan Drugs Revenue and Market Share by Region (2013-2018)
3.3 United States Orphan Drugs Price by Region (2013-2018)
4 United States Orphan Drugs Sales (Volume) and Revenue (Value) by Type (Product Category) (2013-2018)
4.1 United States Orphan Drugs Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Orphan Drugs Revenue and Market Share by Type (2013-2018)
4.3 United States Orphan Drugs Price by Type (2013-2018)
4.4 United States Orphan Drugs Sales Growth Rate by Type (2013-2018)
5 United States Orphan Drugs Sales (Volume) by Application (2013-2018)
5.1 United States Orphan Drugs Sales and Market Share by Application (2013-2018)
5.2 United States Orphan Drugs Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities
6 United States Orphan Drugs Players/Suppliers Profiles and Sales Data
6.1 Novartis AG
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Orphan Drugs Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Novartis AG Orphan Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.1.4 Main Business/Business Overview
6.2 Bristol-Myers Squibb Company
6.2.2 Orphan Drugs Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Bristol-Myers Squibb Company Orphan Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.2.4 Main Business/Business Overview
6.3 Celgene Corporation
6.3.2 Orphan Drugs Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Celgene Corporation Orphan Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.3.4 Main Business/Business Overview
6.4 F. Hoffmann-La Roche Ltd.
6.4.2 Orphan Drugs Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 F. Hoffmann-La Roche Ltd. Orphan Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.4.4 Main Business/Business Overview
6.5 Pfizer, Inc.
6.5.2 Orphan Drugs Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Pfizer, Inc. Orphan Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.5.4 Main Business/Business Overview
6.6 Sanofi S.A.
6.6.2 Orphan Drugs Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Sanofi S.A. Orphan Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.6.4 Main Business/Business Overview
6.7 Alexion Pharmaceuticals, Inc.
6.7.2 Orphan Drugs Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Alexion Pharmaceuticals, Inc. Orphan Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.7.4 Main Business/Business Overview
6.8 Eli Lilly and Company
6.8.2 Orphan Drugs Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Eli Lilly and Company Orphan Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.8.4 Main Business/Business Overview
6.9 Novo Nordisk A/S
6.9.2 Orphan Drugs Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Novo Nordisk A/S Orphan Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.9.4 Main Business/Business Overview
6.10 AstraZeneca
6.10.2 Orphan Drugs Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 AstraZeneca Orphan Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.10.4 Main Business/Business Overview
6.11 Eisai Co., Ltd.
6.12 Daiichi Sankyo Company Limited
6.13 Bayer AG
6.14 GlaxoSmithKline
6.15 Merck & Co., Inc.
6.16 Johnson & Johnson
6.17 Biogen, Inc.
6.18 Shire
6.19 Amgen, Inc.
MRRbiz supports your business intelligence needs with over 700,000 market research reports, company profiles, data books, and regional market data sheets in its repository. Our document database is updated by the hour, which means that you always have access to fresh data spanning over 300 industries and their sub-segments.
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Toll Free: 866-997-4948
(USA-Canada)
Tel: +1-518-621-2074
E: sales@marketresearchreports.biz
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release United States Orphan Drugs Market Size (Sales Volume) Market Share 2018-2025 here
News-ID: 1020297 • Views: …
More Releases from MarketResearchReports.biz
Hydro-flyers Market: Moving Towards a Brighter Future
A hydro-flyer is an adventure sporting device which uses the propulsion of water jet technology to create continuous flight movement, where the lift and movement are controlled by the flyer. Hydro-flyers sporting devices make use of the flow of water power to drive the flyer to reach soaring heights. The rise in water sporting facilities is one of the major factors that promote the growth and demand for hydro-flyers in…
Outdoor Floodlights: Technology and Market Dynamics
Outdoor floodlights is a reliable, highly efficient, and economical solution for a wide range of outdoor applications. These lights are resistant to temperature fluctuations and they remain stable even in extreme climatic conditions. Unlike the traditional lights, floodlights remain stable and functional even in harsh climatic conditions. This makes them ideal for use in any climate and any outdoor application. Outdoor floodlights save a significant amount of energy and consume…
Snow Helmets Market Future Prospects and Regional Outlook
Riders are riding faster and getting bolder day by day. Hence, safety equipment need to be updated as per the requirement and changing time. Earlier, helmets were primarily used by extreme skiers and racers. They were used only on slopes. However, later, the use of helmets was made compulsory. Earlier, bulky black helmets were used by riders, which are outdated at present. Currently, new stylish helmets that can match with…
Predictions for 2019: Global Sparkling Water Dispensers Industry Is Set to Boom
Sparkling water dispensers are equipment used for dispensing carbonated water. These dispensers mix the still, filtered water with carbon dioxide before dispensing. Sparkling water dispensers are mostly used in households and commercial establishments such as amusement parks, hotels, restaurants, and sports arenas. A sparkling water dispenser has separate outlets for hot water and cold water. The hot water outlet does not require a separate filtration process. However, cold water is…
More Releases for Orphan
Acquired Orphan Blood Disease Market
Acquired Orphan Blood Disease Market to reach over USD 18.93 billion by the year 2031 - Exclusive Report by InsightAce Analytic
According to a new report by InsightAce Analytic, the "Acquired Orphan Blood Disease Market" in terms of revenue was estimated to be worth $8.65 billion in 2023 and is poised to reach $18.93 billion by 2031, growing at a CAGR of 10.47% from 2024 to 2031.
Get Free Access to…
Orphan Drugs Market Size to Hit $3199.3 Billion by 2028 | Orphan Drugs Industry …
Market Overview:
According to our experience research team, Orphan Drugs Market was valued at USD 112.36 Billion in 2021, and the global Orphan Drugs industry is projected to reach a value of USD 3199.3 Billion by 2028, at a CAGR of 7.4% during the forecast period 2022-2028
Vantage Market Research is a collection of market research studies on several industries, such as Chemicals, semiconductors & Electronics, Food & Beverages Technology, Energy &…
Orphan Drugs for Cancer Pipeline Analysis
A huge market opportunity is offered by small patient population which suffers from rare or orphan diseases. Among the category of new orphan drugs, Oncology account for the largest disease group in recent years. It has been observed that majority of the orphan drugs in the clinical stages are for rare cancer disease drugs, and are in the late stages of the pipeline. Some of the drugs are being developed…
US Orphan Drug Pipeline Analysis
In recent years, the pharmaceutical industry has been experiencing a paradigm shift. While a large pool of patients was considered as a major source of revenue for pharma companies in the past, the focus is now gradually shifting to small sections of patients suffering from rare disease. In US, this pool of patients is gradually growing and orphan drugs are becoming an extremely attractive business proposition for the pharmaceuticals industry.…
Europe Orphan Drugs Pipeline Analysis
“Europe Orphan Drugs Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drug profiles under Orphan Drugs status in Europe. Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Chemical Formula, Country of Development and detailed analysis on the development process. The information for particular drug…
Global Orphan Drug Pipeline Analysis
In recent years, the pharmaceutical industry has been experiencing a paradigm shift. While a large pool of patients was considered as a major source of revenue for pharma companies in the past, the focus is now gradually shifting to small sections of patients suffering from rare disease. In US & Europe, this pool of patients is gradually growing and orphan drugs are becoming an extremely attractive business proposition for the…
